About
Cellular & Protein-Based Therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalNorth & South Carolina
Clinical Trials (10)
View allTotal Trials
10
As Lead Sponsor
8
As Collaborator
2
Total Enrollment
582
By Phase
PHASE2: 3PHASE1/PHASE2: 2PHASE1: 3
By Status
ACTIVE_NOT_RECRUITING: 4RECRUITING: 3NOT_YET_RECRUITING: 1ENROLLING_BY_INVITATION: 1COMPLETED: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
Today
Hover over trial bars to see details
Recent Trials
NCT07215403Lead Sponsor
Prescriptive Infusion Algorithm (PIA)
PHASE2Not yet recruiting
12 participants
Started: May 1, 2026 · Completed: Mar 1, 2028
NCT07081841Lead Sponsor
AB-1005 Long-Term Follow-up Study
N/AEnrolling by invitation
132 participants
Started: Sep 4, 2025 · Completed: Mar 30, 2038
NCT06285643Lead Sponsor
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
PHASE2Recruiting
87 participants
Started: Jun 11, 2024 · Completed: Nov 30, 2027
NCT05598333Lead Sponsor
Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure
PHASE2Recruiting
150 participants
Started: Oct 20, 2023 · Completed: Dec 31, 2030
NCT05230459Lead Sponsor
A Study to Evaluate the Safety of AB-1003 (Previously LION-101) in Subjects With Genetic Confirmation of LGMD2I/R9 (Part1)
PHASE1/PHASE2Recruiting
10 participants
Started: May 15, 2023 · Completed: Dec 31, 2028
Locations (1)
Headquarters
Durham, NC, United States
Map
Loading map...